Contemporary use of beta receptor antagonists in chronic heart failure

Ravi K. Garg; A. Nasser Khan; Allen S. Anderson

doi:10.1007/s12019-002-0019-7

Contemporary use of beta receptor antagonists in chronic heart failure

Ravi K. Garg, A. Nasser Khan, Allen S. Anderson

Producción científica: Article › revisión exhaustiva

1 Cita (Scopus)

Resumen

β-adrenergic receptor antagonists slow disease progression, improve symptoms, and increase survival. They should be considered standard of care for patients with stable heart failure and understanding which drugs provide benefit and how to initiate therapy is crucial to improving prognosis.

Idioma original	English (US)
Páginas (desde-hasta)	207-213
Número de páginas	7
Publicación	Comprehensive Therapy
Volumen	28
N.º	4
DOI	https://doi.org/10.1007/s12019-002-0019-7
Estado	Published - 2002
Publicado de forma externa	Sí

ASJC Scopus subject areas

General Medicine

Acceder al documento

10.1007/s12019-002-0019-7

Otros archivos y enlaces

Citar esto

@article{ac8d4d964c3e4f3ba227944da738789a,

title = "Contemporary use of beta receptor antagonists in chronic heart failure",

abstract = "β-adrenergic receptor antagonists slow disease progression, improve symptoms, and increase survival. They should be considered standard of care for patients with stable heart failure and understanding which drugs provide benefit and how to initiate therapy is crucial to improving prognosis.",

author = "Garg, \{Ravi K.\} and Khan, \{A. Nasser\} and Anderson, \{Allen S.\}",

year = "2002",

doi = "10.1007/s12019-002-0019-7",

language = "English (US)",

volume = "28",

pages = "207--213",

journal = "Comprehensive Therapy",

issn = "0098-8243",

publisher = "Humana Press",

number = "4",

}

TY - JOUR

T1 - Contemporary use of beta receptor antagonists in chronic heart failure

AU - Garg, Ravi K.

AU - Khan, A. Nasser

AU - Anderson, Allen S.

PY - 2002

Y1 - 2002

N2 - β-adrenergic receptor antagonists slow disease progression, improve symptoms, and increase survival. They should be considered standard of care for patients with stable heart failure and understanding which drugs provide benefit and how to initiate therapy is crucial to improving prognosis.

AB - β-adrenergic receptor antagonists slow disease progression, improve symptoms, and increase survival. They should be considered standard of care for patients with stable heart failure and understanding which drugs provide benefit and how to initiate therapy is crucial to improving prognosis.

UR - https://www.scopus.com/pages/publications/0036917662

UR - https://www.scopus.com/inward/citedby.url?scp=0036917662&partnerID=8YFLogxK

U2 - 10.1007/s12019-002-0019-7

DO - 10.1007/s12019-002-0019-7

M3 - Article

C2 - 12506490

AN - SCOPUS:0036917662

SN - 0098-8243

VL - 28

SP - 207

EP - 213

JO - Comprehensive Therapy

JF - Comprehensive Therapy

IS - 4

ER -

Contemporary use of beta receptor antagonists in chronic heart failure

Resumen

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto